Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?

Sánchez-Barinas CD, Ocampo M, Tabares L, Bermúdez M, Patarroyo MA, Patarroyo ME.

Biomed Res Int. 2019 Apr 14;2019:8680935. doi: 10.1155/2019/8680935. eCollection 2019.

2.

Behavior and abundance of Anopheles darlingi in communities living in the Colombian Amazon riverside.

Prado CC, Alvarado-Cabrera LA, Camargo-Ayala PA, Garzón-Ospina D, Camargo M, Soto-De León SC, Cubides JR, Celis-Giraldo CT, Patarroyo ME, Patarroyo MA.

PLoS One. 2019 Mar 7;14(3):e0213335. doi: 10.1371/journal.pone.0213335. eCollection 2019.

3.

Synthetic Evaluation of Standard and Microwave-Assisted Solid Phase Peptide Synthesis of a Long Chimeric Peptide Derived from Four Plasmodium falciparum Proteins.

Varela YF, Vanegas Murcia M, Patarroyo ME.

Molecules. 2018 Nov 5;23(11). pii: E2877. doi: 10.3390/molecules23112877.

4.

Association of HIV status with infection by multiple HPV types.

Camargo M, Del Río-Ospina L, Soto-De León SC, Sánchez R, Pineda-Peña AC, Sussmann O, Patarroyo ME, Patarroyo MA.

Trop Med Int Health. 2018 Nov;23(11):1259-1268. doi: 10.1111/tmi.13142. Epub 2018 Sep 10.

PMID:
30133078
5.

The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile.

López C, Yepes-Pérez Y, Díaz-Arévalo D, Patarroyo ME, Patarroyo MA.

Front Cell Infect Microbiol. 2018 May 15;8:156. doi: 10.3389/fcimb.2018.00156. eCollection 2018.

6.

Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components.

Bermudez A, Alba MP, Vanegas M, Patarroyo MA, Patarroyo ME.

Front Chem. 2018 Apr 6;6:106. doi: 10.3389/fchem.2018.00106. eCollection 2018.

7.

Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells.

Carabali-Isajar ML, Ocampo M, Rodriguez DC, Vanegas M, Curtidor H, Patarroyo MA, Patarroyo ME.

Bioorg Med Chem. 2018 May 15;26(9):2401-2409. doi: 10.1016/j.bmc.2018.03.044. Epub 2018 Apr 4.

8.

Micro-epidemiology of mixed-species malaria infections in a rural population living in the Colombian Amazon region.

Camargo M, Soto-De León SC, Del Río-Ospina L, Páez AC, González Z, González E, Cubides JR, Camargo-Ayala PA, Patarroyo ME, Patarroyo MA.

Sci Rep. 2018 Apr 3;8(1):5543. doi: 10.1038/s41598-018-23801-9.

9.

Simultaneous detection of Plasmodium vivax dhfr, dhps, mdr1 and crt-o resistance-associated mutations in the Colombian Amazonian region.

Cubides JR, Camargo-Ayala PA, Niño CH, Garzón-Ospina D, Ortega-Ortegón A, Ospina-Cantillo E, Orduz-Durán MF, Patarroyo ME, Patarroyo MA.

Malar J. 2018 Mar 27;17(1):130. doi: 10.1186/s12936-018-2286-5.

10.

Publisher Correction: Mass & secondary structure propensity of amino acids explain their mutability and evolutionary replacements.

Bohórquez HJ, Suárez CF, Patarroyo ME.

Sci Rep. 2018 Mar 6;8(1):4273. doi: 10.1038/s41598-018-21981-y.

11.

Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions.

Sánchez-Barinas CD, Ocampo M, Vanegas M, Castañeda-Ramirez JJ, Patarroyo MA, Patarroyo ME.

Molecules. 2018 Feb 27;23(3). pii: E526. doi: 10.3390/molecules23030526.

12.

Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective.

Curtidor H, Reyes C, Bermúdez A, Vanegas M, Varela Y, Patarroyo ME.

Molecules. 2017 Dec 12;22(12). pii: E2199. doi: 10.3390/molecules22122199. Review.

13.

A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria.

Lozano JM, Varela Y, Silva Y, Ardila K, Forero M, Guasca L, Guerrero Y, Bermudez A, Alba P, Vanegas M, Patarroyo ME.

Molecules. 2017 Nov 1;22(11). pii: E1837. doi: 10.3390/molecules22111837.

14.

Mass & secondary structure propensity of amino acids explain their mutability and evolutionary replacements.

Bohórquez HJ, Suárez CF, Patarroyo ME.

Sci Rep. 2017 Aug 10;7(1):7717. doi: 10.1038/s41598-017-08041-7. Erratum in: Sci Rep. 2018 Mar 6;8(1):4273.

15.

Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans.

Suárez CF, Pabón L, Barrera A, Aza-Conde J, Patarroyo MA, Patarroyo ME.

Biochem Biophys Res Commun. 2017 Sep 30;491(4):1062-1069. doi: 10.1016/j.bbrc.2017.08.012. Epub 2017 Aug 3.

PMID:
28782517
16.

Critical role of HLA-DRβ* binding peptides' peripheral flanking residues in fully-protective malaria vaccine development.

Reyes C, Rojas-Luna R, Aza-Conde J, Tabares L, Patarroyo MA, Patarroyo ME.

Biochem Biophys Res Commun. 2017 Jul 29;489(3):339-345. doi: 10.1016/j.bbrc.2017.05.123. Epub 2017 May 23.

PMID:
28549586
17.

Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion.

Díaz DP, Ocampo M, Varela Y, Curtidor H, Patarroyo MA, Patarroyo ME.

Mol Cell Biochem. 2017 Jun;430(1-2):149-160. doi: 10.1007/s11010-017-2962-8. Epub 2017 Feb 15.

PMID:
28205097
18.

Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors.

Del Río-Ospina L, Soto-DE León SC, Camargo M, Sánchez R, Moreno-Pérez DA, Pérez-Prados A, Patarroyo ME, Patarroyo MA.

Epidemiol Infect. 2017 May;145(7):1479-1490. doi: 10.1017/S0950268817000188. Epub 2017 Feb 10.

PMID:
28185605
19.

Functionally relevant proteins in Plasmodium falciparum host cell invasion.

Patarroyo ME, Alba MP, Rojas-Luna R, Bermudez A, Aza-Conde J.

Immunotherapy. 2017 Jan;9(2):131-155. doi: 10.2217/imt-2016-0091. Review.

PMID:
28128713
20.

The role of pi-interactions and hydrogen bonds in fully protective synthetic malaria vaccine development.

Reyes C, Moreno-Vranich A, Patarroyo ME.

Biochem Biophys Res Commun. 2017 Mar 11;484(3):501-507. doi: 10.1016/j.bbrc.2017.01.077. Epub 2017 Jan 19.

PMID:
28111344
21.

A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.

Barreto-Santamaría A, Curtidor H, Arévalo-Pinzón G, Herrera C, Suárez D, Pérez WH, Patarroyo ME.

Front Microbiol. 2016 Dec 20;7:2006. doi: 10.3389/fmicb.2016.02006. eCollection 2016.

22.

Plasmodium malariae in the Colombian Amazon region: you don't diagnose what you don't suspect.

Niño CH, Cubides JR, Camargo-Ayala PA, Rodríguez-Celis CA, Quiñones T, Cortés-Castillo MT, Sánchez-Suárez L, Sánchez R, Patarroyo ME, Patarroyo MA.

Malar J. 2016 Nov 29;15(1):576.

23.

The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents.

Del Río-Ospina L, Soto-De León SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, Patarroyo MA.

PLoS One. 2016 Nov 15;11(11):e0166502. doi: 10.1371/journal.pone.0166502. eCollection 2016.

24.

Far from the Madding Crowd: the Molecular Basis for Immunological Escape of Plasmodium falciparum.

Patarroyo ME, Aza-Conde J, Moreno-Vranich A, Pabón L, Varela Y, Patarroyo MA.

Curr Issues Mol Biol. 2017;22:65-78. Epub 2016 Oct 4.

25.

High Plasmodium malariae Prevalence in an Endemic Area of the Colombian Amazon Region.

Camargo-Ayala PA, Cubides JR, Niño CH, Camargo M, Rodríguez-Celis CA, Quiñones T, Sánchez-Suárez L, Patarroyo ME, Patarroyo MA.

PLoS One. 2016 Jul 28;11(7):e0159968. doi: 10.1371/journal.pone.0159968. eCollection 2016.

26.

TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria.

Alba MP, Suarez CF, Varela Y, Patarroyo MA, Bermudez A, Patarroyo ME.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):654-660. doi: 10.1016/j.bbrc.2016.06.115. Epub 2016 Jun 27.

PMID:
27363338
27.

Mycobacterium tuberculosis PE9 protein has high activity binding peptides which inhibit target cell invasion.

Díaz DP, Ocampo M, Pabón L, Herrera C, Patarroyo MA, Munoz M, Patarroyo ME.

Int J Biol Macromol. 2016 May;86:646-55. doi: 10.1016/j.ijbiomac.2015.12.081. Epub 2016 Feb 2.

PMID:
26851205
28.

How frequently do clusters occur in hierarchical clustering analysis? A graph theoretical approach to studying ties in proximity.

Leal W, Llanos EJ, Restrepo G, Suárez CF, Patarroyo ME.

J Cheminform. 2016 Jan 25;8:4. doi: 10.1186/s13321-016-0114-x. eCollection 2016.

29.

Chlamydia trachomatis Frequency in a Cohort of HPV-Infected Colombian Women.

Quinónez-Calvache EM, Ríos-Chaparro DI, Ramírez JD, Soto-De León SC, Camargo M, Del Río-Ospina L, Sánchez R, Patarroyo ME, Patarroyo MA.

PLoS One. 2016 Jan 25;11(1):e0147504. doi: 10.1371/journal.pone.0147504. eCollection 2016.

30.

Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus.

Patarroyo ME, Patarroyo MA, Pabón L, Curtidor H, Poloche LA.

Vaccine. 2015 Dec 22;33(52):7525-37. doi: 10.1016/j.vaccine.2015.09.109. Epub 2015 Oct 19. Review.

31.

Cell-Peptide Specific Interaction Can Inhibit Mycobacterium tuberculosis H37Rv Infection.

Rodríguez DC, Ocampo M, Reyes C, Arévalo-Pinzón G, Munoz M, Patarroyo MA, Patarroyo ME.

J Cell Biochem. 2016 Apr;117(4):946-58. doi: 10.1002/jcb.25379. Epub 2015 Sep 30.

PMID:
26375297
32.

Malaria Parasite Survival Depends on Conserved Binding Peptides' Critical Biological Functions.

Patarroyo ME, Arevalo-Pinzon G, Reyes C, Moreno-Vranich A, Patarroyo MA.

Curr Issues Mol Biol. 2016;18:57-78. Epub 2015 Aug 28.

33.

Recent advances in the development of a chemically synthesised anti-malarial vaccine.

Curtidor H, Patarroyo ME, Patarroyo MA.

Expert Opin Biol Ther. 2015;15(11):1567-81. doi: 10.1517/14712598.2015.1075505. Epub 2015 Aug 4. Review.

PMID:
26239009
34.

The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.

Del Río-Ospina L, Soto-De León SC, Camargo M, Moreno-Pérez DA, Sánchez R, Pérez-Prados A, Patarroyo ME, Patarroyo MA.

BMC Cancer. 2015 Mar 5;15:100. doi: 10.1186/s12885-015-1126-z.

35.

IMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine development.

Patarroyo ME, Bermúdez A, Alba MP, Vanegas M, Moreno-Vranich A, Poloche LA, Patarroyo MA.

PLoS One. 2015 Apr 16;10(4):e0123249. doi: 10.1371/journal.pone.0123249. eCollection 2015.

36.

The Malaria Parasite's Achilles' Heel: Functionally-relevant Invasion Structures.

Patarroyo ME, Alba MP, Reyes C, Rojas-Luna R, Patarroyo MA.

Curr Issues Mol Biol. 2016;18:11-9. Epub 2015 Apr 1.

37.

Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines.

Rodríguez DC, Ocampo M, Varela Y, Curtidor H, Patarroyo MA, Patarroyo ME.

Pathog Dis. 2015 Apr;73(3). pii: ftu020. doi: 10.1093/femspd/ftu020. Epub 2014 Dec 11.

PMID:
25743470
38.

Protecting capacity against malaria of chemically defined tetramer forms based on the Plasmodium falciparum apical sushi protein as potential vaccine components.

Vanegas M, Bermúdez A, Guerrero YA, Cortes-Vecino JA, Curtidor H, Patarroyo ME, Lozano JM.

Biochem Biophys Res Commun. 2014 Aug 15;451(1):15-23. doi: 10.1016/j.bbrc.2014.06.143. Epub 2014 Jul 22.

PMID:
25063026
39.

Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro.

Ocampo M, Curtidor H, Vanegas M, Patarroyo MA, Patarroyo ME.

Chem Biol Drug Des. 2014 Dec;84(6):626-41. doi: 10.1111/cbdd.12365. Epub 2014 Jul 10.

40.

Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.

Soto-De León SC, Del Río-Ospina L, Camargo M, Sánchez R, Moreno-Pérez DA, Pérez-Prados A, Patarroyo ME, Patarroyo MA.

BMC Infect Dis. 2014 Jul 16;14:395. doi: 10.1186/1471-2334-14-395.

41.

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.

Camargo M, Soto-De Leon SC, Munoz M, Sanchez R, Peña-Herrera D, Pineda-Peña AC, Sussmann O, Paez C, Perez-Prados A, Patarroyo ME, Patarroyo MA.

BMC Cancer. 2014 Jun 18;14:451. doi: 10.1186/1471-2407-14-451.

42.

Characterising a microsatellite for DRB typing in Aotus vociferans and Aotus nancymaae (Platyrrhini).

López C, Suárez CF, Cadavid LF, Patarroyo ME, Patarroyo MA.

PLoS One. 2014 May 12;9(5):e96973. doi: 10.1371/journal.pone.0096973. eCollection 2014.

43.

Gauche(+) side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine.

Bermúdez A, Calderon D, Moreno-Vranich A, Almonacid H, Patarroyo MA, Poloche A, Patarroyo ME.

Vaccine. 2014 Apr 11;32(18):2117-26. doi: 10.1016/j.vaccine.2014.02.003. Epub 2014 Feb 28.

PMID:
24582630
44.

Using the PfEMP1 head structure binding motif to deal a blow at severe malaria.

Patarroyo ME, Alba MP, Curtidor H, Vanegas M, Almonacid H, Patarroyo MA.

PLoS One. 2014 Feb 7;9(2):e88420. doi: 10.1371/journal.pone.0088420. eCollection 2014.

45.

Identification and diversity of killer cell Ig-like receptors in Aotus vociferans, a New World monkey.

Garzón-Ospina D, López C, Cadavid LF, Patarroyo ME, Patarroyo MA.

PLoS One. 2013 Nov 6;8(11):e79731. doi: 10.1371/journal.pone.0079731. eCollection 2013.

46.

Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells.

Ocampo M, Rodríguez DC, Rodríguez J, Bermúdez M, Muñoz CM, Patarroyo MA, Patarroyo ME.

Bioorg Med Chem. 2013 Nov 1;21(21):6650-6. doi: 10.1016/j.bmc.2013.08.018. Epub 2013 Aug 15.

PMID:
23993672
47.

Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Pineda-Peña AC, Perez-Prados A, Patarroyo ME, Patarroyo MA.

J Clin Microbiol. 2013 Nov;51(11):3688-93. doi: 10.1128/JCM.01302-13. Epub 2013 Aug 28.

48.

Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion.

Curtidor H, Patiño LC, Arévalo-Pinzón G, Vanegas M, Patarroyo ME, Patarroyo MA.

Peptides. 2014 Mar;53:210-7. doi: 10.1016/j.peptides.2013.07.028. Epub 2013 Aug 8.

PMID:
23932940
49.

Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds.

Lozano JM, Guerrero YA, Alba MP, Lesmes LP, Escobar JO, Patarroyo ME.

Amino Acids. 2013 Oct;45(4):913-35. doi: 10.1007/s00726-013-1541-x. Epub 2013 Jul 9.

50.

Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine.

Ocampo M, Patarroyo MA, Vanegas M, Alba MP, Patarroyo ME.

Crit Rev Microbiol. 2014 May;40(2):117-45. doi: 10.3109/1040841X.2013.763221. Epub 2013 Feb 27. Review.

PMID:
23445450

Supplemental Content

Loading ...
Support Center